AGILE THERAPEUTICS INC - COM (AGRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q1 2024

Type / Class
Equity / COM
Symbol
AGRX on OTC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$20 0
2023 Q4 10 $20 +$20 $2.00 1
2022 Q2 0 $0 -$4,036,000 0
2022 Q1 19,246,771 $4,036,379 +$216,841 $0.21 31
2021 Q4 37,648,372 $18,385,903 +$2,589,908 $0.49 45
2021 Q3 31,750,559 $30,507,855 -$2,822,129 $0.96 47
2021 Q2 34,381,236 $45,725,567 -$6,236,478 $1.33 64
2021 Q1 38,278,231 $79,607,991 -$6,670,177 $2.08 75
2020 Q4 36,962,273 $106,079,929 +$4,560,202 $2.87 77
2020 Q3 38,854,832 $118,103,778 +$1,348,307 $3.04 78
2020 Q2 38,477,855 $106,962,531 +$17,293,150 $2.78 80
2020 Q1 33,012,349 $61,398,868 +$9,849,447 $1.86 62
2019 Q4 27,218,584 $68,048,017 +$11,041,795 $2.50 48
2019 Q3 24,045,810 $28,507,745 +$4,759,528 $1.18 34
2019 Q2 19,579,436 $26,668,006 +$1,511,068 $1.46 25
2019 Q1 18,537,143 $27,999,006 +$13,818,988 $1.51 26
2018 Q4 8,989,295 $5,210,301 -$126,361 $0.58 25
2018 Q3 14,440,164 $5,317,192 -$1,825,840 $0.37 28
2018 Q2 17,860,582 $8,801,006 -$11,635,555 $0.49 35
2018 Q1 24,684,950 $63,439,344 +$834,568 $2.57 47
2017 Q4 19,276,119 $51,878,407 -$8,261,946 $2.69 49
2017 Q3 19,862,788 $88,560,333 +$9,337,165 $4.46 47
2017 Q2 23,075,157 $86,523,961 +$651,287 $3.75 44
2017 Q1 22,956,380 $73,613,746 -$6,544,132 $3.21 52
2016 Q4 23,414,839 $133,464,314 -$3,408,392 $5.70 66
2016 Q3 24,007,260 $167,572,890 -$2,012,176 $6.98 56
2016 Q2 24,188,154 $184,076,969 -$1,041,324 $7.61 56
2016 Q1 24,385,422 $151,445,916 +$34,210,256 $6.21 53
2015 Q4 16,544,218 $161,472,097 +$190,834 $9.76 48
2015 Q3 16,764,628 $112,991,911 -$2,942,948 $6.74 49
2015 Q2 14,161,252 $121,637,838 +$4,871,369 $8.59 56
2015 Q1 13,579,222 $125,872,000 +$25,113,229 $9.27 38
2014 Q4 10,869,692 $66,738,000 +$1,066,480 $6.14 21
2014 Q3 5,551,405 $40,515,000 -$2,730,772 $7.30 21
2014 Q2 8,047,184 $70,171,000 +$70,170,000 $8.72 19